Candel Therapeutics appoints Martine Zimmermann, PharmD, to its board
Candel Therapeutics, Inc. said it appointed Martine Zimmermann, PharmD, to its board of directors. The company is a clinical-stage biopharmaceutical focused on multimodal immunotherapies for cancer.